Holen Sie sich die Stockscreener-App
9.61
1.33%
-0.13
Vorhandelsmarkt:
9.34
-0.27
-2.81%
Amneal Pharmaceuticals Inc Aktie (AMRX) Neueste Nachrichten
Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal’s FDA Approval of Sodium Oxybate Oral Solution, Novel Orexin Agonists, and Next-Generation Sleep-Wake Modulators Redefine Narcolepsy Care | D - Barchart.com
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
JPMorgan Chase & Co. Boosts Amneal Pharmaceuticals (NASDAQ:AMRX) Price Target to $14.00 - MarketBeat
Jones Financial Companies Lllp Takes $1.73 Million Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Caxton Associates LLP Buys New Stake in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Excessive Daytime Sleepiness Pipeline Insight 2025: Amneal's - openPR.com
Woodline Partners LP Has $12.60 Million Stock Position in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Is Amneal Pharmaceuticals Inc in a long term uptrend2025 Year in Review & Stepwise Entry and Exit Trade Signals - خودرو بانک
AQR Capital Management LLC Buys 408,677 Shares of Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Acadian Asset Management LLC Has $21.76 Million Stock Holdings in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Aug Rallies: Can Amneal Pharmaceuticals Inc continue delivering strong returns2025 Momentum Check & Target Return Focused Picks - خودرو بانک
Analyst Downgrade: What are the future prospects of Amneal Pharmaceuticals Inc2025 Key Highlights & Weekly High Momentum Picks - خودرو بانک
Aug Big Picture: Does Amneal Pharmaceuticals Inc. have pricing powerGap Up & Weekly Top Performers Watchlists - خودرو بانک
Goldman Sachs Group Inc. Has $7.85 Million Holdings in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
Aug Final Week: Is Amneal Pharmaceuticals Inc stock undervalued right nowQuarterly Profit Summary & Daily Growth Stock Investment Tips - خودرو بانک
Nasdaq Moves: Is Amneal Pharmaceuticals Inc forming a double bottomQuarterly Trade Report & Long-Term Capital Growth Strategies - خودرو بانک
Amneal secures FDA approval for sodium oxybate solution - World Pharmaceutical Frontiers
Aug Outlook: Can Amneal Pharmaceuticals Inc continue delivering strong returnsWeekly Profit Recap & Consistent Profit Alerts - خودرو بانک
Portfolio Update: Can Amneal Pharmaceuticals Inc continue delivering strong returnsEarnings Overview Summary & Risk Controlled Swing Alerts - خودرو بانک
Amneal Pharmaceuticals (NASDAQ:AMRX) Hits New 52-Week HighShould You Buy? - MarketBeat
Amneal receives FDA approval of treatment for narcoleptic sufferers - ROI-NJ
Ophthalmic Packaging Market Worth USD 23.65 Billion by 2034 | Towards Packaging - GlobeNewswire Inc.
Ieq Capital LLC Takes $288,000 Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
Why Amneal (AMRX) Stock Is Up Today - Yahoo Finance
Amneal wins FDA nod for generic targeting Jazz Pharma’s Xyrem - Seeking Alpha
Amneal Pharmaceuticals Wins US FDA Approval for Generic Version of Narcolepsy Drug Xyrem - MarketScreener
Amneal receives US FDA approval of Sodium Oxybate Oral Solution - MarketScreener
Amneal Receives U.S. FDA Approval of Sodium Oxybate Oral Solution - GlobeNewswire
150,000 Narcolepsy Patients Get New Option: Amneal's FDA-Approved Generic Breaks Single-Maker Market - Stock Titan
Amneal Pharmaceuticals: A Large, Diversified Clinical Portfolio That Keeps Growing (AMRX) - Seeking Alpha
Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by Raymond James Financial Inc. - MarketBeat
Northern Trust Corp Reduces Position in AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
684,116 Shares in AMNEAL PHARMACEUTICALS, INC. $AMRX Bought by Cubist Systematic Strategies LLC - MarketBeat
Anti-Parkinson's Drugs Global Markets to 2030 with AbbVie, Amneal Pharmaceuticals, Acadia Pharmaceut - PharmiWeb.com
Anti-Parkinson's Drugs Global Markets to 2030 with AbbVie, Amneal Pharmaceuticals, Acadia Pharmaceuticals, Supernus Pharmaceuticals and Teva Pharmaceutical DominatingResearchAndMarkets.com - Business Wire
Amneal Pharmaceuticals stock hits 52-week high at $9.79 By Investing.com - Investing.com Nigeria
Amneal Pharmaceuticals stock hits 52-week high at $9.79 - Investing.com
Is Amneal Pharmaceuticals Inc. a strong growth stockJuly 2025 Analyst Calls & Community Shared Stock Ideas - beatles.ru
AMNEAL PHARMACEUTICALS, INC. $AMRX Shares Bought by Dark Forest Capital Management LP - MarketBeat
Is Amneal Pharmaceuticals Inc.’s ROE strong enough2025 Analyst Calls & Free Real-Time Volume Trigger Notifications - beatles.ru
Should you wait for a breakout in Amneal Pharmaceuticals Inc.Bear Alert & Fast Moving Stock Trade Plans - Newser
Can machine learning forecast Amneal Pharmaceuticals Inc. recoveryPortfolio Value Summary & Stock Portfolio Risk Management - Newser
Amneal Pharmaceuticals, Inc. $AMRX Shares Bought by Nantahala Capital Management LLC - MarketBeat
FDA Warns Amneal Pharmaceuticals Over Use of Contaminated IV Bags in Sterile Injectable Drug Production - geneonline.com
Amneal gets FDA nod for generic version of Risperdal Consta - MSN
Does Amneal Pharmaceuticals Inc. have pricing powerDollar Strength & Weekly Stock Breakout Alerts - خودرو بانک
Trexquant Investment LP Acquires 167,631 Shares of AMNEAL PHARMACEUTICALS, INC. $AMRX - MarketBeat
Should you avoid Amneal Pharmaceuticals Inc. stock right nowJuly 2025 Action & Low Risk Profit Maximizing Plans - خودرو بانک
Using R and stats models for Amneal Pharmaceuticals Inc. forecastingEarnings Risk Report & Advanced Technical Signal Analysis - Newser
What is the Moat Score of Amneal Pharmaceuticals Inc.2025 Biggest Moves & Reliable Entry Point Alerts - خودرو بانک
Why Amneal Pharmaceuticals Inc. is moving todayGap Down & Smart Money Movement Alerts - Newser
FDA approves Amneal’s generic risperidone for schizophrenia treatment By Investing.com - Investing.com Australia
Is Amneal Pharmaceuticals Inc. showing insider buyingCEO Change & Free Expert Verified Stock Movement Alerts - خودرو بانک
Tools to monitor Amneal Pharmaceuticals Inc. recovery probabilityShort Setup & AI Powered Market Trend Analysis - Newser
Published on: 2025-09-05 05:42:34 - Newser
Regression analysis insights on Amneal Pharmaceuticals Inc. performanceWeekly Market Report & Accurate Intraday Trading Signals - Newser
1.75%
1.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):